Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis
- PMID: 29506541
- PMCID: PMC5839069
- DOI: 10.1186/s13018-018-0747-8
Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis
Abstract
Background: This meta-analysis aimed to assess whether the specific nonsteroidal anti-inflammatory drug (NSAID) naproxen has a role in reducing the occurrence of heterotopic ossification after hip surgery.
Methods: Potential studies were identified in the following electronic databases: PubMed, EMBASE, Web of Science, Cochrane Library, and Google. We included studies involving hip surgery patients in which the intervention group received naproxen and the control group received placebo. The occurrence of heterotopic ossification and complications were the final outcomes. Stata 13.0 was used for the meta-analysis.
Results: Four randomized controlled trials (RCTs) involving 269 patients were ultimately included in this meta-analysis. The use of naproxen was associated with a significant reduction in the occurrence of heterotopic ossification at 1.5-, 3-, 6-, and 12-month follow-ups (P < 0.05). There was no significant difference in the occurrence of complications between treatment and control groups (P > 0.05).
Conclusion: Our analysis indicates that naproxen can decrease the occurrence of heterotopic ossification without increasing complications in hip surgery patients. Due to the limited number of studies included, more high-quality RCTs are needed to identify the optimal dose of naproxen.
Keywords: Heterotopic ossification; Hip surgery; Meta-analysis; Naproxen.
Conflict of interest statement
Author contributions
RM and GHC conceived the study design. LJZ and XCZ performed the study, collected the data, and contributed to the study design. LJZ and XCZ prepared the manuscript. RM, GHC, and XCZ edited the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
None
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures








Similar articles
-
A systematic review and meta-analysis of naproxen for prevention heterotopic ossification after hip surgery.Medicine (Baltimore). 2019 Apr;98(14):e14607. doi: 10.1097/MD.0000000000014607. Medicine (Baltimore). 2019. PMID: 30946309 Free PMC article.
-
The Effect of NSAID Prophylaxis and Operative Variables on Heterotopic Ossification After Hip Arthroscopy.Am J Sports Med. 2014 Jun;42(6):1359-64. doi: 10.1177/0363546514526361. Epub 2014 Mar 24. Am J Sports Med. 2014. PMID: 24664136
-
Hip Arthroscopy and Heterotopic Ossification: Is NSAID Prophylaxis Justified? Commentary on an article by James T. Beckmann, MD, MS, et al.: "Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial".J Bone Joint Surg Am. 2015 Dec 16;97(24):e80. doi: 10.2106/JBJS.O.00922. J Bone Joint Surg Am. 2015. PMID: 26677244 No abstract available.
-
Naproxen in the prevention of heterotopic ossification after total hip replacement.Clin Orthop Relat Res. 1999 Dec;(369):279-88. doi: 10.1097/00003086-199912000-00029. Clin Orthop Relat Res. 1999. PMID: 10611883 Clinical Trial.
-
Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.Expert Opin Pharmacother. 2008 Apr;9(5):767-86. doi: 10.1517/14656566.9.5.767. Expert Opin Pharmacother. 2008. PMID: 18345954 Review.
Cited by
-
Incidence of Heterotopic Ossification with NSAID Prophylaxis Is Low After Open and Arthroscopic Hip Preservation Surgery.Arthrosc Sports Med Rehabil. 2021 Jul 29;3(5):e1309-e1314. doi: 10.1016/j.asmr.2021.06.001. eCollection 2021 Oct. Arthrosc Sports Med Rehabil. 2021. PMID: 34712968 Free PMC article.
-
Heterotopic Ossification After Arthroscopic Procedures: A Scoping Review of the Literature.Orthop J Sports Med. 2022 Jan 18;10(1):23259671211060040. doi: 10.1177/23259671211060040. eCollection 2022 Jan. Orthop J Sports Med. 2022. PMID: 35071654 Free PMC article.
-
Nonsteroidal Antiinflammatory Drugs as Potential Disease-Modifying Medications in Axial Spondyloarthritis.Arthritis Rheumatol. 2020 Apr;72(4):518-528. doi: 10.1002/art.41164. Epub 2020 Feb 24. Arthritis Rheumatol. 2020. PMID: 31705611 Free PMC article. Review.
-
The hypoxic microenvironment: a driving force for heterotopic ossification progression.Cell Commun Signal. 2020 Feb 7;18(1):20. doi: 10.1186/s12964-020-0509-1. Cell Commun Signal. 2020. PMID: 32028956 Free PMC article. Review.
-
Effectiveness and priority of irradiation and six NSAIDs in prevention heterotopic ossification after total hip arthroplasty: a network meta-analysis of randomized controlled studies.Front Pharmacol. 2025 May 21;16:1601349. doi: 10.3389/fphar.2025.1601349. eCollection 2025. Front Pharmacol. 2025. PMID: 40469979 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical